The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy

The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognosti...

Full description

Saved in:
Bibliographic Details
Published inRadiation oncology journal Vol. 34; no. 3; pp. 168 - 176
Main Authors Bae, Bong Kyung, Kim, Jae-Chul
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society for Radiation Oncology 01.09.2016
대한방사선종양학회
Subjects
Online AccessGet full text
ISSN2234-1900
2234-3156
2234-3164
DOI10.3857/roj.2016.01669

Cover

Abstract The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated. Forty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated. The median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients' prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively). RT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients.
AbstractList The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated. Forty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated. The median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients' prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively). RT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients.
Purpose: The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated. Materials and Methods: Forty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated. Results: The median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients’ prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively). Conclusion: RT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients. KCI Citation Count: 2
PURPOSEThe purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT). In addition, survival of patients and potential prognostic factors of the survival was evaluated.MATERIALS AND METHODSForty-seven patients with PVT or HVT in HCC, referred to our department for radiotherapy, were retrospectively reviewed. For 3D-CRT plans, a gross tumor volume (GTV) was defined as a hypodense filling defect area in the portal vein (PV) or hepatic vein (HV). Survival of patients, and response to radiation therapy (RT) were analyzed. Potential prognostic factors for survival and response to RT were evaluated.RESULTSThe median survival time of 47 patients was 8 months, with 1-year survival rate of 15% and response rate of 40%. Changes in Child-Pugh score, response to RT, Eastern cooperative oncology group performance status (ECOG PS), hepatitis C antibody (HCVAb) positivity, and additional post RT treatment were statistically significant prognostic factors for survival in univariate analysis (p = 0.000, p = 0.018, p = 0.000, p = 0.013, and p = 0.047, respectively). Of these factors, changes in Child-Pugh score, and response to RT were significant for patients' prognosis in multivariate analysis (p = 0.001 and p = 0.035, respectively).CONCLUSIONRT could constitute a reasonable treatment option for patients with PVT or HVT in HCC with acceptable toxicity. Changes in Child-Pugh score, and response to RT were statistically significant factors of survival of patients.
Author Kim, Jae-Chul
Bae, Bong Kyung
Author_xml – sequence: 1
  givenname: Bong Kyung
  surname: Bae
  fullname: Bae, Bong Kyung
– sequence: 2
  givenname: Jae-Chul
  surname: Kim
  fullname: Kim, Jae-Chul
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27545294$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002148165$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1UUlr3DAUFiUlSZNceyw69jJT7ZIvhRCaNBAolOlZaGS5o8SW3CdPIP--sifpBtXC0-N9C-h7g45STgGht5SsuZH6A-T7NSNUretVzSt0yhgXK06lOnp-04aQE3RRyj2pSxGpFDlGJ0xLIVkjTlHa7AKGUMacSsC5w9MO8rDNJRYcU-0CHjNMrsePofYZ8C6Mbor-0Nez9NmHvt_3DrB34GPKg8NTxuDaWMF5EQI3Pp2j153rS7h4rmfo2_WnzdXn1d2Xm9ury7uVF4xPKxOcYS3RyrTSEMpIqzTVTDozb-IZ2_o6MJxpr31DRJC0axnvjBJ627T8DL0_6Cbo7IOPNru41O_ZPoC9_Lq5tUrppuEV-vEAHffbIbQ-pAlcb0eIg4Onhfj3JMVdlXm0kiglJPntNUL-sQ9lskMs83-4FPK-WGq4FMRIPnu9-9Prl8lLHhUgDgAPuRQInfVxWn6wWsfeUmLn5G1N3s7J2yX5Slv_Q3tR_g_hJ85lsTg
CitedBy_id crossref_primary_10_1016_j_jceh_2024_102386
crossref_primary_10_1016_j_ctro_2017_04_003
crossref_primary_10_3389_fonc_2022_829708
crossref_primary_10_4143_crt_2017_096
crossref_primary_10_18632_oncotarget_19219
crossref_primary_10_1186_s12885_021_08469_1
crossref_primary_10_2147_CMAR_S296020
crossref_primary_10_1016_j_jceh_2023_03_006
Cites_doi 10.1016/S0360-3016(03)00434-6
10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M
10.1016/j.ijrobp.2011.03.019
10.1097/00000658-200103000-00012
10.1016/j.radonc.2007.07.005
10.1016/j.ijrobp.2005.12.031
10.1097/00000658-199906000-00005
10.1002/cncr.10694
10.1016/S0360-3016(02)02915-2
10.1016/j.semradonc.2011.05.003
10.1053/j.gastro.2007.04.061
10.1016/0360-3016(91)90171-Y
10.1007/s004320050189
10.1186/1748-717X-9-101
10.1002/hep.510290145
10.1002/cncr.24139
10.1097/00000421-200204000-00019
10.1093/jjco/hys082
10.1093/jjco/hyl006
10.3857/roj.2012.30.3.146
10.1002/cncr.21043
10.3857/roj.2014.32.3.170
10.1016/S0360-3016(02)02846-8
10.1007/s11605-009-0854-2
10.1111/j.1349-7006.2008.00981.x
10.1016/j.ijrobp.2008.06.1486
10.1097/01.coc.0000239147.60196.11
10.1159/000343855
10.1002/hep.24199
10.1016/j.ijrobp.2009.06.092
10.1046/j.1440-1746.2001.02496.x
10.1016/S0167-8140(02)00061-0
ContentType Journal Article
Copyright Copyright © 2016 The Korean Society for Radiation Oncology 2016
Copyright_xml – notice: Copyright © 2016 The Korean Society for Radiation Oncology 2016
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.3857/roj.2016.01669
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2234-3156
2234-3164
EndPage 176
ExternalDocumentID oai_kci_go_kr_ARTI_667993
PMC5066450
27545294
10_3857_roj_2016_01669
Genre Journal Article
GroupedDBID 5-W
8JR
8XY
9ZL
AAKDD
AAYXX
ABDBF
ACUHS
ADBBV
ADRAZ
AEGXH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
EF.
GX1
HYE
KQ8
M48
OK1
PGMZT
RPM
KVFHK
NPM
7X8
5PM
.UV
ACYCR
ID FETCH-LOGICAL-c423t-8ea82d0768d580120d671725a8a8a80c22bc5808327c7c904e51fd23f8647b9d3
IEDL.DBID M48
ISSN 2234-1900
IngestDate Tue Nov 21 21:03:56 EST 2023
Thu Aug 21 18:11:18 EDT 2025
Fri Jul 11 02:10:53 EDT 2025
Thu Jan 02 22:19:49 EST 2025
Thu Apr 24 22:52:10 EDT 2025
Tue Jul 01 01:32:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Hepatocellular carcinoma
Portal vein
Radiotherapy
Hepatic vein
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c423t-8ea82d0768d580120d671725a8a8a80c22bc5808327c7c904e51fd23f8647b9d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000881.2016.34.3.001
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3857/roj.2016.01669
PMID 27545294
PQID 1835408533
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_667993
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5066450
proquest_miscellaneous_1835408533
pubmed_primary_27545294
crossref_citationtrail_10_3857_roj_2016_01669
crossref_primary_10_3857_roj_2016_01669
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-09-01
PublicationDateYYYYMMDD 2016-09-01
PublicationDate_xml – month: 09
  year: 2016
  text: 2016-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Radiation oncology journal
PublicationTitleAlternate Radiat Oncol J
PublicationYear 2016
Publisher The Korean Society for Radiation Oncology
대한방사선종양학회
Publisher_xml – name: The Korean Society for Radiation Oncology
– name: 대한방사선종양학회
References ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
15822130 - Cancer. 2005 Jun 1;103(11):2419-26
22689916 - Jpn J Clin Oncol. 2012 Aug;42(8):721-9
19296182 - J Gastrointest Surg. 2009 Jun;13(6):1078-83
17716760 - Radiother Oncol. 2007 Sep;84(3):266-71
18760547 - Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1155-63
12065102 - Radiother Oncol. 2002 Apr;63(1):41-5
16613896 - Jpn J Clin Oncol. 2006 Apr;36(4):212-7
11422619 - J Gastroenterol Hepatol. 2001 Jun;16(6):660-5
24804174 - Liver Cancer. 2014 Mar;3(1):18-30
11943901 - Am J Clin Oncol. 2002 Apr;25(2):189-93
9719503 - J Cancer Res Clin Oncol. 1998;124(7):397-400
2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
16690430 - Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):426-34
8635087 - Cancer. 1996 Jun 1;77(11):2217-22
21939854 - Semin Radiat Oncol. 2011 Oct;21(4):256-63
12182986 - Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):156-62
21374666 - Hepatology. 2011 Mar;53(3):1020-2
19156918 - Cancer. 2009 Mar 15;115(6):1245-52
9862851 - Hepatology. 1999 Jan;29(1):62-7
25324989 - Radiat Oncol J. 2014 Sep;32(3):170-8
19032365 - Cancer Sci. 2008 Dec;99(12):2510-7
11224626 - Ann Surg. 2001 Mar;233(3):379-84
10363892 - Ann Surg. 1999 Jun;229(6):790-9; discussion 799-800
12909223 - Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):113-9
17570226 - Gastroenterology. 2007 Jun;132(7):2557-76
17148993 - Am J Clin Oncol. 2006 Dec;29(6):568-75
23170294 - Radiat Oncol J. 2012 Sep;30(3):146-51
12095546 - Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21
21621346 - Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11
20171524 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S94-100
24779518 - Radiat Oncol. 2014 Apr 29;9:101
12209752 - Cancer. 2002 Aug 1;95(3):588-95
References_xml – ident: ref26
  doi: 10.1016/S0360-3016(03)00434-6
– ident: ref2
  doi: 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M
– ident: ref17
  doi: 10.1016/j.ijrobp.2011.03.019
– ident: ref6
  doi: 10.1097/00000658-200103000-00012
– ident: ref27
  doi: 10.1016/j.radonc.2007.07.005
– ident: ref23
  doi: 10.1016/j.ijrobp.2005.12.031
– ident: ref4
  doi: 10.1097/00000658-199906000-00005
– ident: ref7
  doi: 10.1002/cncr.10694
– ident: ref20
  doi: 10.1016/S0360-3016(02)02915-2
– ident: ref30
  doi: 10.1016/j.semradonc.2011.05.003
– ident: ref1
  doi: 10.1053/j.gastro.2007.04.061
– ident: ref31
  doi: 10.1016/0360-3016(91)90171-Y
– ident: ref3
  doi: 10.1007/s004320050189
– ident: ref24
  doi: 10.1186/1748-717X-9-101
– ident: ref10
  doi: 10.1002/hep.510290145
– ident: ref15
  doi: 10.1002/cncr.24139
– ident: ref28
  doi: 10.1097/00000421-200204000-00019
– ident: ref16
  doi: 10.1093/jjco/hys082
– ident: ref29
  doi: 10.1093/jjco/hyl006
– ident: ref14
  doi: 10.3857/roj.2012.30.3.146
– ident: ref5
  doi: 10.1002/cncr.21043
– ident: ref18
  doi: 10.3857/roj.2014.32.3.170
– ident: ref22
  doi: 10.1016/S0360-3016(02)02846-8
– ident: ref8
  doi: 10.1007/s11605-009-0854-2
– ident: ref12
  doi: 10.1111/j.1349-7006.2008.00981.x
– ident: ref13
  doi: 10.1016/j.ijrobp.2008.06.1486
– ident: ref11
  doi: 10.1097/01.coc.0000239147.60196.11
– ident: ref9
  doi: 10.1159/000343855
– ident: ref19
  doi: 10.1002/hep.24199
– ident: ref32
  doi: 10.1016/j.ijrobp.2009.06.092
– ident: ref25
  doi: 10.1046/j.1440-1746.2001.02496.x
– ident: ref21
  doi: 10.1016/S0167-8140(02)00061-0
– reference: 10363892 - Ann Surg. 1999 Jun;229(6):790-9; discussion 799-800
– reference: 19296182 - J Gastrointest Surg. 2009 Jun;13(6):1078-83
– reference: 19156918 - Cancer. 2009 Mar 15;115(6):1245-52
– reference: 16690430 - Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):426-34
– reference: 20171524 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S94-100
– reference: 12182986 - Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):156-62
– reference: 12065102 - Radiother Oncol. 2002 Apr;63(1):41-5
– reference: 2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
– reference: 16613896 - Jpn J Clin Oncol. 2006 Apr;36(4):212-7
– reference: 24779518 - Radiat Oncol. 2014 Apr 29;9:101
– reference: 22689916 - Jpn J Clin Oncol. 2012 Aug;42(8):721-9
– reference: 17716760 - Radiother Oncol. 2007 Sep;84(3):266-71
– reference: 12909223 - Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):113-9
– reference: 11943901 - Am J Clin Oncol. 2002 Apr;25(2):189-93
– reference: 18760547 - Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1155-63
– reference: 15822130 - Cancer. 2005 Jun 1;103(11):2419-26
– reference: 23170294 - Radiat Oncol J. 2012 Sep;30(3):146-51
– reference: 21939854 - Semin Radiat Oncol. 2011 Oct;21(4):256-63
– reference: 12095546 - Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21
– reference: 9862851 - Hepatology. 1999 Jan;29(1):62-7
– reference: 11224626 - Ann Surg. 2001 Mar;233(3):379-84
– reference: 17148993 - Am J Clin Oncol. 2006 Dec;29(6):568-75
– reference: 21374666 - Hepatology. 2011 Mar;53(3):1020-2
– reference: 17570226 - Gastroenterology. 2007 Jun;132(7):2557-76
– reference: 12209752 - Cancer. 2002 Aug 1;95(3):588-95
– reference: 25324989 - Radiat Oncol J. 2014 Sep;32(3):170-8
– reference: 9719503 - J Cancer Res Clin Oncol. 1998;124(7):397-400
– reference: 24804174 - Liver Cancer. 2014 Mar;3(1):18-30
– reference: 21621346 - Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11
– reference: 11422619 - J Gastroenterol Hepatol. 2001 Jun;16(6):660-5
– reference: 19032365 - Cancer Sci. 2008 Dec;99(12):2510-7
– reference: 8635087 - Cancer. 1996 Jun 1;77(11):2217-22
SSID ssj0000605660
Score 2.0714374
Snippet The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in hepatocellular...
PURPOSEThe purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in...
Purpose: The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic vein thrombosis (HVT) in...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 168
SubjectTerms Original
방사선과학
Title The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/27545294
https://www.proquest.com/docview/1835408533
https://pubmed.ncbi.nlm.nih.gov/PMC5066450
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002148165
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Radiation oncology journal , 2016, 34(3), , pp.168-176
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUKvXBBVC2wpUWuVImTUT5sxzlUVVUV0Ur01JW4WY7twAJr0-yC4N93Js5uu9VyQUkUWZnEip-dmeeMZwj5yI21tZI5K8rSMc5NzYysHMtcYWTupG8qXDt89lOejvmPc3H-1_9paMDZWmqH-aTG3c3xw-_HzzDgPyHjVEDou3iFPlryGA5Zb5CXoJUkErGzwdRPX2VQ9f2iYVCInIEezFIMxzWPwAjBFSbfrvmKutoIXbvOEv3fofIfDXWyQ7YH05J-SX3hFXnhw2sSoB_QLjnCehpbinkRpk2cTWZ0EqDkaXp5eu-hHDt66dHJ2qYy7H054gQ_eqxSi8mHQpwaOo-0w8gGCC1N67ge35DxybdfX0_ZkGOBWTCk5kx5owqHv-OcQGWVOQkErxBG4ZbZomgsXIBxX9nK1hn3Im9dUbZK8qqpXblLNkMMfp9QrniuatnWmehpIfBTo2zpnBFWeaFGhC2aUtshADnmwbjRQEQQBQ0oaERB9yiMyNFS_jaF3nhS8gMgo6_tRGO0bDxfRH3daeAE37WUFRhhILPATcMIwlYzwce7mc77uS8wW0BmL-G4rG_RDUakWkF4KYD1rV4Jk8s-SrcAY46L7O2z7zwgW_CKPPmlvSOb8-7OvwcLaN4c9l37sJ-a-gNEowXd
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+response+of+thrombosis+in+the+portal+vein+or+hepatic+vein+in+hepatocellular+carcinoma+to+radiation+therapy&rft.jtitle=Radiation+oncology+journal&rft.au=Bae%2C+Bong+Kyung&rft.au=Kim%2C+Jae-Chul&rft.date=2016-09-01&rft.pub=The+Korean+Society+for+Radiation+Oncology&rft.issn=2234-1900&rft.eissn=2234-3164&rft.volume=34&rft.issue=3&rft.spage=168&rft.epage=176&rft_id=info:doi/10.3857%2Froj.2016.01669&rft_id=info%3Apmid%2F27545294&rft.externalDocID=PMC5066450
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-1900&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-1900&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-1900&client=summon